학술논문
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial
Document Type
Article
Author
Acosta, Edward; Douglas, Steve; Fry, Carrie; Kuryla, Samantha; Perdue, Lynette; Samson, Pearl; Spector, Steven; Toye, MariPat; Tustin, Nancy; Watson, Scott; Worrell, Carol; Zheng, Nan; Nachman, Sharon ; Alvero, Carmelita; Teppler, Hedy; Homony, Brenda; Rodgers, Anthony J; Graham, Bobbie L; Fenton, Terence; Frenkel, Lisa M; Browning, Renee S; Hazra, Rohan; Wiznia, Andrew A
Source
In The Lancet HIV December 2018 5(12):e715-e722
Subject
Language
ISSN
2352-3018